Judy Felgenhauer

Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial

Leonardo R. Brandão, Matteo Luciani, Lisa Bomgaars et al. · The Lancet Haematology · 2020 · 149 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +12

Asparaginase Pharmacokinetics After Intensive Polyethylene Glycol-Conjugated L-Asparaginase Therapy for Children with Relapsed Acute Lymphoblastic Leukemia

Douglas S. Hawkins, Julie R. Park, Blythe Thomson et al. · Clinical Cancer Research · 2004 · 109 citations

Medicine, Pharmacokinetics, Pharmacology +16

A pilot study of low‐dose anti‐angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893

Judy Felgenhauer, Michael L. Nieder, Mark Krailo et al. · Pediatric Blood & Cancer · 2012 · 66 citations

Medicine, Oncology, Pharmacotherapy +17

Identification of Discrete Prognostic Groups in Ewing Sarcoma

Erin E. Karski, Elizabeth McIlvaine, Mark R. Segal et al. · Pediatric Blood & Cancer · 2015 · 64 citations · Full text

Medicine, Biostatistics, Oncology +17

Relationship Between Epidemiologic Risk Factors and Clinicopathologic Findings in the Sudden Infant Death Syndrome

Joel E. Haas, James A. Taylor, Abraham B. Bergman et al. · PEDIATRICS · 1993 · 51 citations

Public Health, Child Health, Pediatrics +15